U.S. Supreme Court rules for Teva in over multiple sclerosis drug patent
January 20, 2015 at 10:16 AM EST
WASHINGTON, Jan 20 (Reuters) - The U.S. Supreme Court on Tuesday ruled for Teva Pharmaceutical Industries Ltd in its fight with generic drug manufacturers over patent protections for Copaxone, its top-selling multiple sclerosis drug, by sending the case back to a lower court for further review.